UK consensus on normal tissue dose constraints for stereotactic radiotherapy

UK consensus on normal tissue dose constraints for stereotactic radiotherapy

Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M
פורמט: Journal article
שפה:English
יצא לאור: Elsevier 2017

פריטים דומים

פריטים דומים